Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance
Open Access
- 1 November 1996
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 74 (10) , 1627-1631
- https://doi.org/10.1038/bjc.1996.599
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Receptors for Interleukin (IL)-4 Do Not Associate with the Common γChain, and IL-4 Induces the Phosphorylation of JAK2 Tyrosine Kinase in Human Colon Carcinoma CellsJournal of Biological Chemistry, 1995
- Structure of the IL4 receptor and signal transduction mechanism of IL4Research in Immunology, 1993
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Interleukin-4 is a potent mitogen for capillary endotheliumBiochemical and Biophysical Research Communications, 1991
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989
- Lymphokine regulation of inflammatory processes: Interleukin-4 stimulates fibroblast proliferationClinical Immunology and Immunopathology, 1988
- Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineageNature, 1987
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- Identification of a T cell-derived b cell growth factor distinct from interleukin 2.The Journal of Experimental Medicine, 1982
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978